Showing results (241-250 of 857) with videos related to
Sort By:
Pageof 86
Liver International : Official Journal of the International Association for the Study of the Liver|April 16, 2013
Psychological, lifestyle and social predictors of hepatitis C treatment response: a systematic reviewVictoria A Sublette, Mark W Douglas, Kirsten McCaffery, et al.Cancer Medicine|February 23, 2026
Palliative Care Admission at End-of-Life in Liver Cancer: A 10 Year Population-Based Study of 3565 Deaths in AustraliaRebecca J Mitchell, Shenghan Cai, Jacob George, et al.Journal of Health Psychology|September 30, 2016
Listening to both sides: A qualitative comparison between patients with hepatitis C and their healthcare professionals' perceptions of the facilitators and barriers to hepatitis C treatment adherence and completionVictoria A Sublette, Sian K Smith, Jacob George, et al.Bulletin of the World Health Organization|May 20, 2014
Community-based prevention of hepatitis-B-related liver cancer: Australian insightsMonica C Robotin, Melanie Q Kansil, Mamta Porwal, et al.Plos One|March 27, 2015
Hepatocyte-specific deletion of ARNT (aryl hydrocarbon Receptor Nuclear Translocator) results in altered fibrotic gene expression in the thioacetamide model of liver injuryChristopher Scott, Kuan Cha, Renuka Rao, et al.Frontiers in Cardiovascular Medicine|June 20, 2022
The Translation and Commercialisation of Biomarkers for Cardiovascular Disease-A ReviewSoloman Saleh, Jacob George, Katharine A Kott, et al.Biology|October 27, 2022
Dual Targeting of Soluble Oligomeric and Aggregated Transthyretin with a Monoclonal Antibody Ameliorates Experimental NeuropathyMichael Fassler, Sagi Tshori, Yaron Barac, et al.Gastroenterology|November 16, 2005
NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitisAileen Dela Peña, Isabelle Leclercq, Jacqueline Field, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 14, 2026
Introducing Risk Stratification Reduces Patient Burden and Improves Cost-Effectiveness of Hepatocellular Carcinoma Surveillance for People with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Modelling StudyJoachim Worthington, Anna Kelly, Emily He, et al.Journal of Gastroenterology and Hepatology|December 11, 2008
Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factorsAlexis St George, Adrian Bauman, Amanda Johnston, et al.Pageof 86